Kopran (KOPRAN) | Stock Overview & Key Data
Kopran Performance Comparison
Stock Range
Today's Range
Low: ₹156.92
High: ₹162.21
on August 11, 2025
52 Week Range
Low: ₹155.00
High: ₹369.70
on April 7, 2025
on September 9, 2024
All-Time High: ₹370.45 on December 27, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR7.6B
EPS
7.23
P/E Ratio (TTM)
21.67
Forward P/E
27.64
P/B Ratio
1.46
PEG Ratio
27.64
Div. Yield
1.58%
ROE
7.44%
Beta
0.335
Debt to Equity
28.51
Financial Highlights
Profitability
Gross Margin
36.84%
Operating Margin
7.30%
Profit Margin
5.58%
Returns and Earnings
Return on Assets (TTM)
4.57%
Return on Equity (TTM)
7.44%
EBITDA
INR727.8M
Net Income (TTM)
INR349.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR129.52
Quarterly Revenue Growth (YoY)
-3.00%
Quarterly Earnings Growth (YoY)
-32.90%
Dividend Information
Last 12-Month Dividend
₹3.00
Current Dividend Yield
1.58%
3-Year Average Dividend Yield
1.22%
3-Year Average Annual Dividend
₹3.00
3-Year Total Dividends
₹9.00
Ex-Dividend Date
September 2, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Kopran KOPRAN | 7.57B Small-cap | -2.17% | -9.73% | -14.14% | -5.51% | -24.45% | -41.53% | -14.04% | 123.97% |
| GlaxoSmithKline GLAXO | 455.21B Large-cap | -6.34% | -17.16% | -1.26% | 30.56% | 20.38% | -7.10% | 82.41% | 80.88% |
| Pfizer PFIZER | 228.51B Large-cap | 1.03% | -8.27% | 19.09% | 23.09% | -4.65% | -13.51% | 19.04% | 9.92% |
| Senores SENORES | 30.21B Small-cap | -4.98% | 8.23% | 29.61% | 28.53% | 15.84% | 15.47% | 15.47% | 15.47% |
| Sms Pharmaceuticals SMSPHARMA | 19.90B Small-cap | 0.99% | -3.18% | -6.33% | 14.80% | -10.54% | -21.55% | 184.01% | 144.67% |
| TTK Healthcare TTKHLTCARE | 16.27B Small-cap | -6.59% | -13.59% | -6.89% | -7.93% | -19.11% | -28.62% | 35.35% | 126.25% |
Ownership & Short Interest
Insider Ownership
48.46%
Institutional Ownership
0.40%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
215K
Average 90-Day Volume
195K
Kopran Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Kopran would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is KOPRAN's 52-week high and low?
- In the last 52 weeks, Kopran reached a high of ₹369.70 (on September 9, 2024) and a low of ₹155.00 (on April 7, 2025).
- What is the market cap and P/E ratio for KOPRAN?
- Curious about Kopran's size and valuation? Its market capitalization stands at 7.57B. When it comes to valuation, the P/E ratio (trailing twelve months) is 21.67, and the forward P/E (looking ahead) is 27.64.
- Does KOPRAN pay dividends? If so, what's the yield?
- Yes, Kopran is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.58%, and the company has paid an average of ₹3.00 per share annually over the past 3 years.
- Who are Kopran's main competitors or similar companies to consider before investing?
When looking at Kopran, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO455.21B Healthcare Drug Manufacturers - General -7.10% 82.41% Pfizer
PFIZER228.51B Healthcare Drug Manufacturers - General -13.51% 19.04% Senores
SENORES30.21B Healthcare Drug Manufacturers - General 15.47% 15.47% Sms Pharmaceuticals
SMSPHARMA19.90B Healthcare Drug Manufacturers - General -21.55% 184.01% TTK Healthcare
TTKHLTCARE16.27B Healthcare Drug Manufacturers - General -28.62% 35.35% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Kopran Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Kopran's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.44%, the Debt to Equity ratio from the most recent quarter is 28.51, and its Gross Profit Margin stands at 36.84%.
- What is the recent revenue and earnings growth for KOPRAN?
- Looking at Kopran's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by -3.00%, and quarterly earnings saw a YoY growth of -32.90%.
- How much of KOPRAN stock is held by insiders and institutions?
- Wondering who owns Kopran stock? Company insiders (like executives and directors) hold about 48.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.40%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.